Active & open research studies
The following is a list of studies that the UCSF Sarcoidosis Research Program is participating in and are open to enrollment
Risk Indicator of Sarcoidosis Evolution - Unified Protocol study (RISE-UP)
The goal is to develop prediction models (also known as risk assessment tools) that can help doctors prognosticate their patients with sarcoidosis using clinical information and blood test results. Two centers are currently enrolling patients (University of Maryland in Baltimore and UT Southwestern University in Dallas).
To achieve the goals of the study, participants will be asked to schedule a follow-up visit approximately every six months for up to three years. At these visits, pulmonary function tests, a blood draw, and clinical questionnaires will be performed. Learn more about the RISE-UP study via ClinicalTrials.gov.
(The protocol is published PMCID: PMC10083794)
Acthar Study
The goal is to measure blood biomarkers related to interferon inflammation in patients taking Acthar gel. Acthar gel is an FDA-approved gel injection with anti-inflammatory properties that is administered either intramuscularly or subcutaneously.
The study involves up to seven visits to the UCSF Parnassus Campus in San Francisco, Calif. over the course of up to six months.
Research participants will be asked to come for study visits every two weeks for the first month and then monthly until the end of the study. The target population is between the ages of 18 - 65 years old. Procedures will include a blood draw, breathing tests, and questionnaires.